Pharmacy Formulary Updates Effective January 2024
Date: 12/01/23
Effective January 1, 2024, Arizona Complete Health-Complete Care Plan (AzCH-CCP) and Care1st will implement AHCCCS formulary changes based on the recommendations from the October 25, 2023, AHCCCS Pharmacy & Therapeutics (P & T) Committee.
The Preferred Drug Lists including these recent updates are available on our websites.
- AzCH-CCP: www.azcompletehealth.com > For Providers > Pharmacy > Preferred Drug Lists
- Care1st: www.care1staz.com > For Providers > Pharmacy > Preferred Drug Lists
We encourage all prescribing clinicians to review our Preferred Drug Lists (PDL) for preferred formulary alternatives prior to prescribing. The table below highlights some of the January Formulary changes.
Drug Class | Drug(s) Removed from Formulary
| Preferred Alternative(s) on Formulary (NEW or current alternatives) | Utilization Management (PA, STEP, QL, AGE)** | *Grandfathering permitted (Y/N) |
---|---|---|---|---|
Anticonvulsants New Class | The remaining agents in this class are Non-Preferred | *For a complete list of preferred agents in this class, please visit our website. The below list is not all inclusive. 1. Banzel Suspension 2. Banzel tablet 3. Carbatrol 4. Carbamazepine 5. Cloabazam Suspension 6. Clobazam tablet 7. Diastat (Rectal) 8. Dilantin 9. Divlaproex Sprinkle 10. Epidiolex 11. Ethosuximide 12. Felbamate 13. Fycompa 14. Lancosamide 15. Lamotrigine 16. Topiramate 17. Valproic Acid Solution 18. Zonisamide | QL: Nayzilam, Valtoco Nasal spray
PA requirements for current agents on the PDL will remain the same | Y |
Antifungals- Topical | Clotrimazole Sol. (OTC) Ketodan Foam Ketodan Foam Kit Votriza-AL | 1. Clotrimazole Sol. (RX) NEW 2. Ciclopirox Sol. 3. Ketoconazole Shampoo 4. Nystatin Powder 5. Tolfanate powder 6. Terbinafine cream | N/A | N |
Calcium Channel Blockers | Norliqva | 1. Katerzia
| PA required for >7 years old | N |
Hereditary Angioedema Agents (HAE) | Orladeyo Firazyr | 1. Haegarda (Sub-Q) NEW 2. Icatibant (Sub-Q) NEW 3. Cinryze (IV) 4. Berinert (IV) 5. Kalbitor (Sub-Q) | PA | Y |
Immunologic Agents | N/A | 1. Adbry (NEW) 2. Dupixent | PA | N |
Movement Disorders | N/A | 1. Austedo XR (NEW) 2. Austedo XR Titration Packet (NEW) 3. Austedo 4. Ingrezza | PA | N |
Multiple Sclerosis- New Class | The remaining agents in this class are Non-Preferred | 1. Avonex (IM) 2. Avonex Pen (IM) 3. Copaxone 20 mg/ml 4. Copaxone 40 mg/ml 5. Dalfampridine ER (Oral) 6. Dimethyl Fumarate DR (AG) (Oral) 7. Dimethyl Fumarate DR (Oral) 8. Fingolimod (Oral) 9. Kesimpta (Sub-Q) 10. Ocrevus (IV) 11. Rebif Rebidose Pen (Sub-Q) 12. Rebif (Sub-Q) 13. Teriflunomide tab (Oral) 14. Tysabri (IV) | PA | Y |
Sedative Hypnotics | N/A |
1. Zolpidem ER (NEW)
| PA required for < 6 years old & PA required for > 1 hypnotic drug | N |
Steroids- Topicals | N/A | 1. Fluocinolone Acetonide Sol. (Topical) NEW 2. Oralone (Dental) NEW 3. Triamcinolone Paste (Dental) NEW 4. Betamethasone Dipropionate Ointment (Topical) NEW | QL | N |
For AzCH-CCP questions: Contact the pharmacy team (888) 788-4408 (Options 3, 7)
For Care1st questions: Contact the pharmacy team (866) 560-4042 (Options 5, 5)